100 Multislice CT in Coronary Heart Disease <strong>KCE</strong> Reports 82 153. Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making. 1991;11(2):88-94. 154. Van den Bruel A, Cleemput I, Aertgeerts B, Ramaekers D, Buntinx F. The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed. J Clin Epidemiol. 2007;60(11):1<strong>116</strong>-22. 155. Musto C, Simon P, Nicol E, Tanigawa J, Davies SW, Oldershaw PJ, et al. 64-multislice computed tomography in consecutive patients with suspected or proven coronary artery disease: initial single center experience. Int J Cardiol. 2007;114(1):90-7. 156. Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med. 2007;357(22):2277-84. 157. Gaibazzi N. Letter by Gaibazzi regarding article, "Usefulness of 64-slice cardiac computed tomographic angiography for diagnosing acute coronary syndromes and predicting clinical outcome in emergency department patients with chest pain of uncertain origin". Circulation. 2007;<strong>116</strong>(12):e354; author reply e5. 158. Hamon M, Biondi-Zoccai GGL, Malagutti P, Agostoni P, Morello R, Valgimigli M, et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. J Am Coll Cardiol. 2006;48(9):1896-910. 159. Schuijf JD, van der Wall EE, Bax JJ. Changing paradigm: a<strong>the</strong>rosclerosis versus ischaemia. Eur J Nucl Med Mol Imaging. 2007;34(1):1-3. 160. Rahman SL, Kelion AD. Nuclear cardiology in <strong>the</strong> UK: do we apply evidence based medicine? Heart. 2004;90 Suppl 5:v37-40. 161. Cleemput I, Van Wilder P, Vrijens F, Huybrechts M, D R. Guidelines for Pharmacoeconomic Evaluations in Belgium. Brussels: Belgian Health Care Knowledge Centre (<strong>KCE</strong>); 2008 April 2008. Health Technology Assessment (HTA) 78C 162. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, et al. Comparison of coronary-artery bypass surgery and stenting for <strong>the</strong> treatment of multivessel disease. N Engl J Med. 2001;344(15):1117-24. 163. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095-108. 164. Scuffham PA, Chaplin S. An economic evaluation of fluvastatin used for <strong>the</strong> prevention of cardiac events following successful first percutaneous coronary intervention in <strong>the</strong> UK. Pharmacoeconomics. 2004;22(8):525-35. 165. Scuffham PA, Chaplin S. A cost-effectiveness analysis of fluvastatin in patients with diabetes after successful percutaneous coronary intervention. Clin Ther. 2005;27(9):1467-77. 166. Kuntz KM, Tsevat J, Goldman L, Weinstein MC. Cost-effectiveness of routine coronary angiography after acute myocardial infarction. Circulation. 1996;94(5):957-65. 167. Décision du 23 août 2007 de l’Union nationale des caisses d’assurance maladie relative à la liste des actes et prestations pris en charge par l’assurance maladie. In: MINISTÈRE DE LA SANTÉ DE LA JEUNESSE ET DES SPORTS, editor.: Journal Officiel; 2007.
This page is left intentionally blank.